99
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis and Antiviral Evaluation of Some Novel Tricyclic Pyrazolo[3,4‐b]indole Nucleosides

, &
Pages 805-812 | Received 20 Aug 2003, Accepted 22 Mar 2004, Published online: 17 Aug 2006
 

Abstract

Novel pyrazolo[3,4‐b]indole nucleoside analogs were synthesized from the corresponding 3‐formyl‐2‐chloroindole and 3‐cyano‐2‐chloroindole nucleosides by treatment with hydrazine. Very few examples of pyrazolo[3,4‐b]indole heterocycles have been published in the literature and this is the first synthesis of nucleoside analogs containing this heterocycle. These new pyrazolo[3,4‐b]indole nucleosides were active against human cytomegalovirus and herpes simplex virus type 1, but this activity was not well separated from cytotoxicity.

In honor and celebration of the 70th birthday of Professor Leroy B. Townsend.

Acknowledgments

We wish to thank Julie M. Breitenbach and Kathy Z. Borysko for expert performance of antiviral and cytotoxicity assays. These studies were supported by training grant T32‐GM07767 and research grant P01‐AI46390 from the National Institutes of Health.

Notes

In honor and celebration of the 70th birthday of Professor Leroy B. Townsend.

aThe pyrazolo[3,4‐b]indoles reported in Ref. Citation13 were synthesized by a dipolar cycloaddition reaction and may actually be pyrazolo[4,3‐b]indoles.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.